By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DVS Sciences today announced it has raised $14.6 million in a Series A financing round, which will be used to build up the company's manufacturing capabilities for its multiplexed single cell analysis technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.